Alikem Limited (AKE.CA) Fundamental Analysis & Valuation

TSX:AKE • AU0000193666

Current stock price

8.86 CAD
-0.05 (-0.56%)
Last:

This AKE.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. AKE.CA Profitability Analysis

1.1 Basic Checks

  • AKE had positive earnings in the past year.
  • AKE had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: AKE reported negative net income in multiple years.
  • In multiple years AKE reported negative operating cash flow during the last 5 years.
AKE.CA Yearly Net Income VS EBIT VS OCF VS FCFAKE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 8.47%, AKE belongs to the top of the industry, outperforming 94.81% of the companies in the same industry.
  • AKE has a Return On Equity of 12.98%. This is amongst the best in the industry. AKE outperforms 95.04% of its industry peers.
  • The Return On Invested Capital of AKE (12.94%) is better than 97.76% of its industry peers.
  • AKE had an Average Return On Invested Capital over the past 3 years of 6.50%. This is significantly below the industry average of 12.70%.
  • The 3 year average ROIC (6.50%) for AKE is below the current ROIC(12.94%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.47%
ROE 12.98%
ROIC 12.94%
ROA(3y)3.62%
ROA(5y)2.24%
ROE(3y)4.75%
ROE(5y)2.86%
ROIC(3y)6.5%
ROIC(5y)N/A
AKE.CA Yearly ROA, ROE, ROICAKE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10

1.3 Margins

  • AKE has a Profit Margin of 36.57%. This is amongst the best in the industry. AKE outperforms 98.58% of its industry peers.
  • In the last couple of years the Profit Margin of AKE has grown nicely.
  • AKE's Operating Margin of 72.27% is amongst the best of the industry. AKE outperforms 99.76% of its industry peers.
  • AKE's Gross Margin of 84.30% is amongst the best of the industry. AKE outperforms 99.29% of its industry peers.
  • AKE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 72.27%
PM (TTM) 36.57%
GM 84.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y27.05%
GM growth 3Y136.76%
GM growth 5Y26.6%
AKE.CA Yearly Profit, Operating, Gross MarginsAKE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. AKE.CA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AKE is creating some value.
  • Compared to 1 year ago, AKE has about the same amount of shares outstanding.
  • Compared to 1 year ago, AKE has an improved debt to assets ratio.
AKE.CA Yearly Shares OutstandingAKE.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
AKE.CA Yearly Total Debt VS Total AssetsAKE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

  • An Altman-Z score of 2.56 indicates that AKE is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • AKE has a Altman-Z score (2.56) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of AKE is 1.28, which is an excellent value as it means it would take AKE, only 1.28 years of fcf income to pay off all of its debts.
  • AKE has a Debt to FCF ratio of 1.28. This is amongst the best in the industry. AKE outperforms 95.28% of its industry peers.
  • AKE has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
  • AKE's Debt to Equity ratio of 0.08 is on the low side compared to the rest of the industry. AKE is outperformed by 67.06% of its industry peers.
  • Even though the debt/equity ratio score it not favorable for AKE, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.28
Altman-Z 2.56
ROIC/WACC1.48
WACC8.75%
AKE.CA Yearly LT Debt VS Equity VS FCFAKE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 2.52 indicates that AKE has no problem at all paying its short term obligations.
  • With a Current ratio value of 2.52, AKE perfoms like the industry average, outperforming 50.06% of the companies in the same industry.
  • AKE has a Quick Ratio of 2.23. This indicates that AKE is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of AKE (2.23) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.52
Quick Ratio 2.23
AKE.CA Yearly Current Assets VS Current LiabilitesAKE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. AKE.CA Growth Analysis

3.1 Past

  • AKE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.94%, which is quite impressive.
  • AKE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 142.97% yearly.
  • AKE shows a strong growth in Revenue. In the last year, the Revenue has grown by 62.19%.
  • Measured over the past years, AKE shows a very strong growth in Revenue. The Revenue has been growing by 133.56% on average per year.
EPS 1Y (TTM)28.94%
EPS 3YN/A
EPS 5Y142.97%
EPS Q2Q%-9.87%
Revenue 1Y (TTM)62.19%
Revenue growth 3Y150.24%
Revenue growth 5Y133.56%
Sales Q2Q%15.2%

3.2 Future

  • AKE is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.91% yearly.
  • Based on estimates for the next years, AKE will show a quite strong growth in Revenue. The Revenue will grow by 8.16% on average per year.
EPS Next Y-17.91%
EPS Next 2Y-1.44%
EPS Next 3Y12.46%
EPS Next 5Y0.91%
Revenue Next Year-5.44%
Revenue Next 2Y4.69%
Revenue Next 3Y11.08%
Revenue Next 5Y8.16%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AKE.CA Yearly Revenue VS EstimatesAKE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
AKE.CA Yearly EPS VS EstimatesAKE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

6

4. AKE.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 9.53, the valuation of AKE can be described as reasonable.
  • 94.57% of the companies in the same industry are more expensive than AKE, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of AKE to the average of the S&P500 Index (24.88), we can say AKE is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 11.57, the valuation of AKE can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, AKE is valued cheaply inside the industry as 92.21% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of AKE to the average of the S&P500 Index (22.19), we can say AKE is valued slightly cheaper.
Industry RankSector Rank
PE 9.53
Fwd PE 11.57
AKE.CA Price Earnings VS Forward Price EarningsAKE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 95.16% of the companies in the same industry are more expensive than AKE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.7
EV/EBITDA N/A
AKE.CA Per share dataAKE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • AKE has a very decent profitability rating, which may justify a higher PE ratio.
  • AKE's earnings are expected to grow with 12.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.07
EPS Next 2Y-1.44%
EPS Next 3Y12.46%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AKE.CA Dividend Analysis

5.1 Amount

  • No dividends for AKE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

AKE.CA Fundamentals: All Metrics, Ratios and Statistics

Alikem Limited

TSX:AKE (12/21/2023, 7:00:00 PM)

8.86

-0.05 (-0.56%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A
Earnings (Next)01-04
Inst Owners21.93%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.68B
Revenue(TTM)1.21B
Net Income(TTM)441.71M
Analysts78.1
Price Target12.46 (40.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.36%
PT rev (3m)-18.73%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-25.58%
EPS NY rev (3m)-39.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-19.99%
Revenue NY rev (3m)-28.73%
Valuation
Industry RankSector Rank
PE 9.53
Fwd PE 11.57
P/S 3.55
P/FCF 16.7
P/OCF 5.42
P/B 1.26
P/tB 1.49
EV/EBITDA N/A
EPS(TTM)0.93
EY10.5%
EPS(NY)0.77
Fwd EY8.64%
FCF(TTM)0.53
FCFY5.99%
OCF(TTM)1.63
OCFY18.45%
SpS2.5
BVpS7.03
TBVpS5.96
PEG (NY)N/A
PEG (5Y)0.07
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 8.47%
ROE 12.98%
ROCE 18.29%
ROIC 12.94%
ROICexc 15.63%
ROICexgc 18.01%
OM 72.27%
PM (TTM) 36.57%
GM 84.3%
FCFM 21.25%
ROA(3y)3.62%
ROA(5y)2.24%
ROE(3y)4.75%
ROE(5y)2.86%
ROIC(3y)6.5%
ROIC(5y)N/A
ROICexc(3y)7.8%
ROICexc(5y)N/A
ROICexgc(3y)9.02%
ROICexgc(5y)N/A
ROCE(3y)9.19%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y27.05%
GM growth 3Y136.76%
GM growth 5Y26.6%
F-Score8
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.28
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 44.23%
Interest Coverage -62.06
Cash Conversion N/A
Profit Quality 58.11%
Current Ratio 2.52
Quick Ratio 2.23
Altman-Z 2.56
F-Score8
WACC8.75%
ROIC/WACC1.48
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)64.83%
Cap/Sales(5y)84.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.94%
EPS 3YN/A
EPS 5Y142.97%
EPS Q2Q%-9.87%
EPS Next Y-17.91%
EPS Next 2Y-1.44%
EPS Next 3Y12.46%
EPS Next 5Y0.91%
Revenue 1Y (TTM)62.19%
Revenue growth 3Y150.24%
Revenue growth 5Y133.56%
Sales Q2Q%15.2%
Revenue Next Year-5.44%
Revenue Next 2Y4.69%
Revenue Next 3Y11.08%
Revenue Next 5Y8.16%
EBIT growth 1Y87.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-19.97%
EBIT Next 3Y10.39%
EBIT Next 5Y7.54%
FCF growth 1Y42.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y79.1%
OCF growth 3YN/A
OCF growth 5YN/A

Alikem Limited / AKE.CA Fundamental Analysis FAQ

What is the fundamental rating for AKE stock?

ChartMill assigns a fundamental rating of 6 / 10 to AKE.CA.


Can you provide the valuation status for Alikem Limited?

ChartMill assigns a valuation rating of 6 / 10 to Alikem Limited (AKE.CA). This can be considered as Fairly Valued.


How profitable is Alikem Limited (AKE.CA) stock?

Alikem Limited (AKE.CA) has a profitability rating of 7 / 10.


Can you provide the financial health for AKE stock?

The financial health rating of Alikem Limited (AKE.CA) is 7 / 10.